UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 173

Sortiert nach

Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndrome

Nature Medicine, 2022-01, Vol.28 (1), p.71-80

2022

Volltextzugriff (PDF)

Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition

Molecular cancer therapeutics, 2009-07, Vol.8 (7), p.1867-1877

2009

Volltextzugriff (PDF)

Real-time PCR-based assay to quantify the relative amount of human and mouse tissue present in tumor xenografts

BMC biotechnology, 2011-12, Vol.11 (1), p.124-124, Article 124

2011

Volltextzugriff (PDF)

Author Correction: Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott–Aldrich syndrome

Nature Medicine, 2022-10, Vol.28 (10), p.2217-2217

2022

Volltextzugriff (PDF)

Gene expression profiling of 49 human tumor xenografts from in vitro culture through multiple in vivo passages--strategies for data mining in support of therapeutic studies

BMC genomics, 2014-05, Vol.15 (1), p.393-393

2014

Volltextzugriff (PDF)

A chemically‐modified inactive antithrombin as a potent antagonist of fondaparinux and heparin anticoagulant activity

Journal of thrombosis and haemostasis, 2013-06, Vol.11 (6), p.1128-1136

2013

Volltextzugriff (PDF)

Diagnostic du déficit en protéine S

Immuno-analyse & biologie spécialisée, 2007-12, Vol.22 (6), p.366-372

2007

Volltextzugriff (PDF)

Schedule-dependent inhibition of hypoxia-inducible factor-1α protein accumulation, angiogenesis, and tumor growth by topotecan in U251-HRE glioblastoma xenografts

Cancer research (Chicago, Ill.), 2004-10, Vol.64 (19), p.6845-6848

2004

Volltextzugriff (PDF)

Vascular endothelial growth factor, as compared with placental growth factor, is increased in severe sepsis but not in organ failure

Journal of thrombosis and haemostasis, 2012-05, Vol.10 (5), p.974-976

2012

Volltextzugriff (PDF)

Therapeutic vulnerability of an in vivo model of alveolar soft part sarcoma (ASPS) to antiangiogenic therapy

Journal of pediatric hematology/oncology, 2009-08, Vol.31 (8), p.561-570

2009

Volltextzugriff (PDF)

Traitement de l’épicondylite par injections locales écho-guidées de plasma riche en plaquettes (PRP) : étude randomisée contrôlée versus placebo avec un suivi d’1 an

Revue de chirurgie orthopédique et traumatologique, 2014-12, Vol.100 (8), p.e6-e7

2014

Volltextzugriff (PDF)

Gross deletions/duplications in PROS1 are relatively common in point mutation-negative hereditary protein S deficiency

Human genetics, 2009-09, Vol.126 (3), p.449-456

2009

Volltextzugriff (PDF)

D’inhabituels et volumineux hématomes chez une jeune patiente atteinte d’un lupus érythémateux systémique

Annales de dermatologie et de vénéréologie, 2015-12, Vol.142 (12), p.S540-S541

2015

Volltextzugriff (PDF)

Accelerated Preclinical Testing Using Transplanted Tumors from Genetically Engineered Mouse Breast Cancer Models

Clinical cancer research, 2007-04, Vol.13 (7), p.2168-2177

2007

Volltextzugriff (PDF)

Plasma levels of the growth arrest‐specific gene 6 product (Gas6) and antiplatelet drug responsiveness in healthy subjects

Journal of thrombosis and haemostasis, 2006-10, Vol.4 (10), p.2283-2284

2006

Volltextzugriff (PDF)

Sepsis and coagulation

Current opinion in critical care, 2005-10, Vol.11 (5), p.454-460

2005

Volltextzugriff (PDF)

Pathogenesis of meningococcal purpura fulminans

Pathogens and disease, 2017-04, Vol.75 (3)

2017

Volltextzugriff (PDF)

Vasocrine formation of tumor cell-lined vascular spaces: Implications for rational design of antiangiogenic therapies

Cancer research (Chicago, Ill.), 2003-06, Vol.63 (11), p.2812-2819

2003

Volltextzugriff (PDF)

A potential role for imaging technology in anticancer efficacy evaluations

European journal of cancer (1990), 2004-04, Vol.40 (6), p.890-898

2004

Volltextzugriff (PDF)

The protein S thrombin‐sensitive region modulates phospholipid binding and the γ‐carboxyglutamic acid‐rich (Gla) domain conformation in a non‐specific manner

Journal of thrombosis and haemostasis, 2006-03, Vol.4 (3), p.704-706

2006

Volltextzugriff (PDF)

Novel human pathological mutations. Gene symbol: PROS1. Disease: Protein S deficiency

Human genetics, 2010-01, Vol.127 (1), p.121-121

2010

Volltextzugriff (PDF)

A fluorine scan of a tubulin polymerization inhibitor isocombretastatin A-4: Design, synthesis, molecular modelling, and biological evaluation

European journal of medicinal chemistry, 2018-01, Vol.143, p.473-490

2018

Volltextzugriff (PDF)

Assessment of the Interplay between Blood and Skin Vascular Abnormalities in Adult Purpura Fulminans

American journal of respiratory and critical care medicine, 2013-09, Vol.188 (6), p.684-692

2013

Volltextzugriff (PDF)

Molecular bases of type II protein S deficiency: the I203‐D204 deletion in the EGF4 domain alters GLA domain function

Journal of thrombosis and haemostasis, 2006-01, Vol.4 (1), p.186-191

2006

Volltextzugriff (PDF)

PB1071 A Single-Domain Antibody Enhancing Protein S Activity Reduces Vaso-Occlusion in a Murine Model of Sickle Cell Disease

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.100837, Article 100837

2023

Volltextzugriff (PDF)

1 – 25 von 173

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(145)
Mit Volltextzugriff
(152)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(78)
Life Sciences & Biomedicine
(65)
Humans
(64)
Biological And Medical Sciences
(39)
Medical Sciences
(36)
Female
(32)
Hematology
(26)
Adult
(23)
Male
(23)
Cardiovascular System & Cardiology
(20)
Middle Aged
(20)
Animals
(18)
Peripheral Vascular Disease
(18)
Hematologic And Hematopoietic Diseases
(15)
Mice
(15)
Protein S Deficiency - Genetics
(15)
Life Sciences
(14)
Platelet Diseases And Coagulopathies
(14)
Aged
(12)
Protein S - Genetics
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndrome

Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition

Real-time PCR-based assay to quantify the relative amount of human and mouse tissue present in tumor xenografts

Author Correction: Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott–Aldrich syndrome

Gene expression profiling of 49 human tumor xenografts from in vitro culture through multiple in vivo passages--strategies for data mining in support of therapeutic studies

A chemically‐modified inactive antithrombin as a potent antagonist of fondaparinux and heparin anticoagulant activity

Diagnostic du déficit en protéine S

Schedule-dependent inhibition of hypoxia-inducible factor-1α protein accumulation, angiogenesis, and tumor growth by topotecan in U251-HRE glioblastoma xenografts

Vascular endothelial growth factor, as compared with placental growth factor, is increased in severe sepsis but not in organ failure

Therapeutic vulnerability of an in vivo model of alveolar soft part sarcoma (ASPS) to antiangiogenic therapy

Traitement de l’épicondylite par injections locales écho-guidées de plasma riche en plaquettes (PRP) : étude randomisée contrôlée versus placebo avec un suivi d’1 an

Gross deletions/duplications in PROS1 are relatively common in point mutation-negative hereditary protein S deficiency

D’inhabituels et volumineux hématomes chez une jeune patiente atteinte d’un lupus érythémateux systémique

Accelerated Preclinical Testing Using Transplanted Tumors from Genetically Engineered Mouse Breast Cancer Models

Plasma levels of the growth arrest‐specific gene 6 product (Gas6) and antiplatelet drug responsiveness in healthy subjects

Sepsis and coagulation

Pathogenesis of meningococcal purpura fulminans

Vasocrine formation of tumor cell-lined vascular spaces: Implications for rational design of antiangiogenic therapies

A potential role for imaging technology in anticancer efficacy evaluations

The protein S thrombin‐sensitive region modulates phospholipid binding and the γ‐carboxyglutamic acid‐rich (Gla) domain conformation in a non‐specific manner

Novel human pathological mutations. Gene symbol: PROS1. Disease: Protein S deficiency

A fluorine scan of a tubulin polymerization inhibitor isocombretastatin A-4: Design, synthesis, molecular modelling, and biological evaluation

Assessment of the Interplay between Blood and Skin Vascular Abnormalities in Adult Purpura Fulminans

Molecular bases of type II protein S deficiency: the I203‐D204 deletion in the EGF4 domain alters GLA domain function

PB1071 A Single-Domain Antibody Enhancing Protein S Activity Reduces Vaso-Occlusion in a Murine Model of Sickle Cell Disease

Suchergebnisse filtern